- Home
- / OncoMed Pharmaceuticals
- / Financials
OncoMed PharmaceuticalsHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CreditSafe score
?
Score changed on Feb 08, 2023
Premium Content
Learn moreFinancial statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|
| Revenue | 37.8M | 39.6M | 25.9M | 25.2M | 38.2M | 44.4M |
| General and administrative expense | 11.6M | 13.8M | 18.6M | 18.8M | 16.8M | 18.2M |
| Operating expense total | 61.7M | 90.2M | 111.5M | 128.5M | 79.1M | 54.5M |
| EBIT | (23.9M) | (50.6M) | (85.6M) | (103.4M) | (41.0M) | (10.0M) |
| EBIT margin, % | -63.3% | -128.0% | -330.3% | -411.0% | -107.4% | -22.6% |
| Interest income | 1.6M | |||||
| Pre tax profit | (24.1M) | (50.5M) | (85.4M) | (103.1M) | (40.1M) | (8.5M) |
| Income tax expense | 1.9M | (509.0K) | 20.0K | 14.0K | (1.1M) | (382.0K) |
| Net Income | (26.1M) | (50.0M) | (85.4M) | (103.1M) | (39.1M) | (8.1M) |
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension